<p class="MsoNormal" style="mso-margin-top-alt: auto;"> This week, please join author Douglas Johns and Associate Editor Thomas Eschenhagen as they discuss the article "An Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor."</p> <p class="MsoNormal" style="mso-margin-top-alt: auto;"> For the episode transcript, visit: <a href= "https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fahajournals.org%2Fdo%2F10.1161%2Fpodcast.20230709.411427&data=05%7C01%7CBridgette.Cain%40wolterskluwer.com%7Cccb5c3b8d24847bcada608db80bc203f%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638245317870841253%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=kBLKDTgMkidb0lcB1ak01rcs%2FSnKyci%2B6F58sCsa454%3D&reserved=0"> https://ahajournals.org/do/10.1161/podcast.20230709.411427</a></p>

Circulation July 18, 2023 Issue

Each 15-minute podcast begins with an overview of the issue's contents and main take-home messages for busy clinicians on the run. This is followed by a deep dive into a featured article of particular clinical significance: views will be heard from both author and editor teams for a "behind the scenes" look at the publication. Expect a fun, highly conversational and clinically-focused session each week!